COAG
Hemab Therapeutics Holdings, Inc.
39.33
+0.56 (+1.44%)
52w low 23.00
55.42 high
50.4% of range
Financial Analysis
| Ratio | Mar 25 | Jun 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|
| Returns | |||||
| Return on Equity | -- | -- | 11.4% | -5.3% | |
| Return on Assets | -- | -- | -12.9% | -5.2% | |
| Return on Inv Capital | -- | -- | 11.9% | -5.8% | |
| Liquidity | |||||
| Current Ratio | -- | -- | 12.85x | 35.85x | |
| Quick Ratio | -- | -- | 12.85x | 35.85x | |
| Cash Ratio | -- | -- | 3.78x | 18.34x | |
| Leverage | |||||
| Debt / Equity | -- | -- | -0.01x | 0.00x | |
| Equity Multiplier | -- | -- | -0.88x | 1.03x | |
| Efficiency | |||||
| Asset Turnover | -- | -- | 0.00x | 0.00x | |
| Effective Tax Rate | 1.2% | -0.0% | -0.1% | -0.4% | |
| Op CF / Net Income | 0.85x | 1.26x | 0.95x | 0.94x | |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--